BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Inscopix Partners With Charles River Laboratories to Provide Neural Circuit Insights to Pharma Via Contract Research

  Together, Brains On-Line and Charles River are a premier early-stage research and development partner for neuroscience drug discovery.

  November 10, 2017

   · 

  2 min read
• Policy

  Vertex Receives CHMP Positive Opinion for ORKAMBI (Lumacaftor/Ivacaftor) for the Treatment of Children With Cystic Fibrosis Ages 6-11 With Two Copies of the F508del Mutation in the European Union

  In other countries, Vertex will begin the country-by-country reimbursement process following Marketing Authorization.

  November 10, 2017

   · 

  8 min read
• Drug Development

  Results From Boehringer Ingelheim’s Six-Month Lung Imaging Study Showed Slowing of Fibrotic Progression in Patients With IPF Treated With Ofev Versus Placebo

  The results are being presented at the PFF Summit 2017, November 9-11 in Nashville, Tenn.

  November 10, 2017

   · 

  7 min read
• Business

  BioSpecifics Technologies Corp. Reports Third Quarter 2017 Financial Results

  Total revenue for the third quarter ended September 30, 2017 was $6.5M compared to $6.9M for the same period in 2016.

  November 10, 2017

   · 

  18 min read
• 

  FDA

  LENSAR Wins FDA OK for IntelliAxis-L - LENSAR Laser System’s Novel Toric Intraocular Lens Alignment Guidance

  The company is introducing the new feature with the latest LENSAR Laser System upgrade.

  November 10, 2017

   · 

  4 min read
• Biotech Beach

  Ontario Health Technology Advisory Committee Recommends Public Funding for Second Sight’s Argus II Retinal Prosthesis System

  Second Sight Medical Products announced that the Argus II Retinal Prosthesis System (“Argus II”) has been recommended for public funding by the Ontario Health Technology Advisory Committee (OHTAC) of Health Quality Ontario.

  November 10, 2017

   · 

  6 min read
• Business

  ERS Genomics and Cellecta Sign License Agreement on CRISPR/Cas9 Genome Editing Patents for Tools and Services

  Financial details of the agreement were not disclosed.

  November 10, 2017

   · 

  3 min read
• Policy

  Tauriga Sciences Enters Into Confidential Settlement Agreement and General Releases in Connection With the Action Against its Former Auditors

  The settlement amount is being funded in its entirety by professional liability insurance for the Defendants.

  November 10, 2017

   · 

  4 min read
• Pharm Country

  Ethicon’s BIOPATCH Protective Disk With CHG Meets New CDC Recommendation and Continues as the Standard of Care to Reduce Intravascular Catheter-Related Blood Stream Infections

  BIOPATCH is the only IV dressing proven in multiple meta-analyses and randomized controlled trials to reduce risk of central line associated bloodstream infections in patients with central and arterial lines.

  November 10, 2017

   · 

  4 min read
• Business

  Dynatronics Corp. Schedules Conference Call to Report Financial Results for First Fiscal Quarter

  Dynatronics today announced that its financial results for the quarter ended September 30, 2017 will be released pre market open on Tuesday, November 14, 2017.

  November 10, 2017

   · 

  1 min read